A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM) | Zendy

James B. Wetmore | Zendy; Konstantin Gurevich | Zendy; Stuart M. Sprague | Zendy; Gerald da Roza | Zendy; John Buerkert | Zendy; Maureen Reiner | Zendy; William G. Goodman | Zendy; Kerry Cooper | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM)

Author(s) -

James B. Wetmore,

Konstantin Gurevich,

Stuart M. Sprague,

Gerald da Roza,

John Buerkert,

Maureen Reiner,

William G. Goodman,

Kerry Cooper

Publication year - 2015

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07050714

Subject(s) - cinacalcet , medicine , secondary hyperparathyroidism , vitamin d and neurology , urology , clinical endpoint , parathyroid hormone , confidence interval , randomized controlled trial , hyperparathyroidism , endocrinology , vitamin d deficiency , calcium

Direct comparison of cinacalcet and vitamin D analogs as monotherapies to lower parathyroid hormone (PTH) levels has not been undertaken.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research